Press "esc" to clear
Go to Advanced Search

Showing results

110 of 1443
  • Embargo expired:
    13-Jun-2018 1:00 PM EDT

Article ID: 695938

Fish “Umbrella” Protects Stem Cells from Sun

Howard Hughes Medical Institute (HHMI)

Stem cells that make blood cells in fish flourish in the shade provided by a newly discovered cellular “umbrella” that keeps them safe from UV damage.

Released:
11-Jun-2018 1:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
Rosenberg_Aaron.jpg

Article ID: 696030

Stem Cell Transplants Extend Life for Multiple Myeloma Patients

UC Davis Comprehensive Cancer Center

Researchers at UC Davis have confirmed that autologous hematopoietic stem cell transplant improves survival for people suffering from multiple myeloma, yet many potentially eligible patients never undergo the procedure.

Released:
12-Jun-2018 2:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
iStock_25371965_600.jpg

Article ID: 695769

In building the brain, cell pedigree matters

Harvard Medical School

Research in mice shows that a protein made by the stem cells that give rise to neurons, but not by neurons themselves, is key to brain cells’ ability to migrate during development and assume their proper positions. This primordial protein acts by clinging onto thousands of sites in the genome, affecting the activity of multiple genes that regulate brain development. The findings could yield valuable clues for a variety of neurodevelopmental disorders.

Released:
7-Jun-2018 11:35 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
CTiDGraphic.JPG
  • Embargo expired:
    5-Jun-2018 7:00 AM EDT

Article ID: 695179

Clinical Trials in a Dish: A Perspective on the Coming Revolution in Drug Development

SLAS (Society for Laboratory Automation and Screening)

Researchers share perspective about Clinical Trials in a Dish (CTiD), a novel strategy that bridges preclinical testing and clinical trials.

Released:
30-May-2018 1:05 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
  • Embargo expired:
    1-Jun-2018 11:00 AM EDT

Article ID: 695305

Phase I Trial Finds Experimental Drug Safe in Treating Chronic Lymphocytic Leukemia

University of California San Diego Health

Reporting results from a first-in-human phase I clinical trial, researchers at University of California San Diego School of Medicine have found that treatment with cirmtuzumab, an experimental monoclonal antibody-based drug, measurably inhibited the “stemness” of chronic lymphocytic leukemia cancer (CLL) cells — their ability to self-renew and resist terminal differentiation and senescence.

Released:
30-May-2018 1:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 668302

Prevention by Social Connections, Refuting Claims on HIV Persistence, Efficient Oral Medicines, and More in the AIDS and HIV News Source

Newswise

The latest research, features, and experts on HIV and AIDS.

Released:
25-May-2018 3:35 PM EDT
EXPERT AVAILABLE
Open in New Tab Add to Favorites
Comment
gregory-pence-2018.jpg

Article ID: 695157

Bioethicist Says Right to Try Act Will Not Be Good for Terminally-Ill Patients

University of Alabama at Birmingham

Released:
25-May-2018 12:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Law and Public Policy

tuszynski_mark.jpg

Article ID: 695025

In a Break with Dogma, Myelin Boosts Neuron Growth in Spinal Cord Injuries

University of California San Diego Health

In a new paper, published in the May 23 online issue of Science Translational Medicine, researchers at University of California San Diego School of Medicine report that adult rat myelin actually stimulated axonal outgrowth in rat neural precursor cells (NPCs) and human induced pluripotent (iPSC)-derived neural stem cells (NSCs).

Released:
23-May-2018 1:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
  • Embargo expired:
    18-May-2018 2:00 PM EDT

Article ID: 694509

Researchers Operate Lab-Grown Heart Cells by Remote Control

University of California San Diego Health

Researchers at University of California San Diego School of Medicine and their collaborators have developed a technique that allows them to speed up or slow down human heart cells growing in a dish on command — simply by shining a light on them and varying its intensity. The cells are grown on a material called graphene, which converts light into electricity, providing a more realistic environment than standard plastic or glass laboratory dishes.

Released:
14-May-2018 11:05 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
Mitchelletal_horizontal.jpg
  • Embargo expired:
    17-May-2018 9:00 AM EDT

Article ID: 694507

Single Surface Protein Boosts Multiple Oncogenic Pathways in Acute Myeloid Leukemia, Study Reveals

The Rockefeller University Press

Researchers from the Albert Einstein College of Medicine in New York have discovered that a signaling protein elevated in patients with acute myeloid leukemia (AML) plays a much wider role in the disease than previously thought. The study, which will be published May 17 in the Journal of Experimental Medicine, raises hopes that current efforts to target this signaling protein could be a successful strategy to treat AML and other blood cancers.

Released:
14-May-2018 10:05 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Showing results

110 of 1443





Chat now!